Biogen Shares Fall ~1.3% Amid Report Intellectual Property Right Patent Trial Against Co.'s '514 Tecfidera By Sawai Has Been Instituted By Patent Trial, Appeal Board As Claims Have Been Determined To Be Likely Invalid